RATIONALE: Despite a well-established relationship between alcohol and risky behavior in the natural environment, laboratory investigations have not reliably shown acute alcohol effects on human risk-taking. OBJECTIVES: The present study was designed to demonstrate a dose-response relationship between acute alcohol administration and human risk taking. Further, this investigation sought to delineate behavioral mechanisms that may be involved in alcohol-induced changes in the probability of risky behavior. METHODS: Using a laboratory measure of risk taking designed to address acute drug effects, 16 adults were administeredplacebo, 0.2, 0.4, and 0.8 g/kg alcohol in a within-subject repeated measures experimental design. The risk-taking task presented subjects with a choice between two response options operationally defined as risky and non-risky. Data analyses examined: breath alcohol level (BAL), subjective effects, response rates, distribution of choices between the risky and non-risky option, and trial-by-trial probabilities of making losing and winning risky responses. RESULTS: The alcohol administration produced the expected changes in BAL, subjective effects, and response rate. Alcohol dose-dependently increased selection of the risky response option, and at the 0.8 g/kg dose, increased the probability of making consecutive losing risky responses following a gain on the risky response option. CONCLUSIONS: Acute alcohol administration can produce measurable changes in human risk-taking under laboratory conditions. Shifts in trial-by-trial response probabilities suggest insensitivity to past rewards and more recent losses when intoxicated, an outcome consistent with previous studies. This shift in sensitivity to consequences is a possible mechanism in alcohol-induced changes in risk taking.
RCT Entities:
RATIONALE: Despite a well-established relationship between alcohol and risky behavior in the natural environment, laboratory investigations have not reliably shown acute alcohol effects on human risk-taking. OBJECTIVES: The present study was designed to demonstrate a dose-response relationship between acute alcohol administration and human risk taking. Further, this investigation sought to delineate behavioral mechanisms that may be involved in alcohol-induced changes in the probability of risky behavior. METHODS: Using a laboratory measure of risk taking designed to address acute drug effects, 16 adults were administered placebo, 0.2, 0.4, and 0.8 g/kg alcohol in a within-subject repeated measures experimental design. The risk-taking task presented subjects with a choice between two response options operationally defined as risky and non-risky. Data analyses examined: breath alcohol level (BAL), subjective effects, response rates, distribution of choices between the risky and non-risky option, and trial-by-trial probabilities of making losing and winning risky responses. RESULTS: The alcohol administration produced the expected changes in BAL, subjective effects, and response rate. Alcohol dose-dependently increased selection of the risky response option, and at the 0.8 g/kg dose, increased the probability of making consecutive losing risky responses following a gain on the risky response option. CONCLUSIONS: Acute alcohol administration can produce measurable changes in human risk-taking under laboratory conditions. Shifts in trial-by-trial response probabilities suggest insensitivity to past rewards and more recent losses when intoxicated, an outcome consistent with previous studies. This shift in sensitivity to consequences is a possible mechanism in alcohol-induced changes in risk taking.
Authors: R A Vogel; G D Frye; J H Wilson; C M Kuhn; K M Koepke; R B Mailman; R A Mueller; G R Breese Journal: Psychopharmacology (Berl) Date: 1980 Impact factor: 4.530
Authors: Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush Journal: Psychopharmacology (Berl) Date: 2006-09-14 Impact factor: 4.530
Authors: Remco W M Zoethout; Wilson L Delgado; Annelies E Ippel; Albert Dahan; Joop M A van Gerven Journal: Br J Clin Pharmacol Date: 2011-03 Impact factor: 4.335
Authors: Jodi M Gilman; Ashley R Smith; James M Bjork; Vijay A Ramchandani; Reza Momenan; Daniel W Hommer Journal: Addict Biol Date: 2014-04-23 Impact factor: 4.280
Authors: Estibaliz Arce; Daniel A Miller; Justin S Feinstein; Murray B Stein; Martin P Paulus Journal: Psychopharmacology (Berl) Date: 2006-10-03 Impact factor: 4.530
Authors: Jeffrey S Simons; Raluca M Simons; Stephen A Maisto; Austin M Hahn; Kyle J Walters Journal: Exp Clin Psychopharmacol Date: 2018-02 Impact factor: 3.157
Authors: Scott D Lane; Oleg V Tcheremissine; Lori M Lieving; Sylvain Nouvion; Don R Cherek Journal: Psychopharmacology (Berl) Date: 2005-04-14 Impact factor: 4.530